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Background: The aim of our study was to evaluate the histological characteristics and prognosis of gastric cancer.
Methods: Clinicopathlogical variables of 932 patients with gastric carcinoma admitted to the Department of
Surgical Oncology at the First Hospital of China Medical University were analyzed retrospectively. Different
histological characteristics of gastric cancer were summarized and assigned score according to the malignancy
defined by WHO classification, the scores were stratified into 4 stage, the prognosis of different stages were
analyzed by Kaplan-Meier analysis and cox regression.
Results: Among the 932 patients, 246 (26.39%) had mixed histology type of gastric cancer. Compared to the pure
histological type, mixed histological type of gastric cancer was significant associated with tumor size, lymph node
metastasis and depth of invasion (all P < 0.05). The 5-year survival rates of advanced and early gastric cancer patients
with mixed type were 40.8% and 83.5% respectively, which were lower than those with pure type (50.0% and
95.8%, P < 0.01). Statistically significant difference with stratification of early and advanced stage could be
observed between patients with the histological grading score. The data showed that the histological score
could be the independent factor of prognosis.
Conclusions: The histological score is an independent factor of gastric cancer, it exerts an excellent ability to
classify survival of patients with gastric carcinoma. It also provides a new strategy and parameter for evaluating
the biological behavior and prognosis of gastric cancer.
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It might be easily thought out that tumor-related factors
such as tumor size, lymphatic invasion, and venous in-
vasion could be an indicator for progressive potential
of malignant tumors [1-3]. However, except for stage
of the tumor, there have not been any criteria using
histopathological tumor-related factors to determine
the outcome of the patients with gastric carcinoma.
Histopathological type is an important prognosis factor,
it is also to determine the extent of surgical resection and* Correspondence: xuhuimian@126.com
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unless otherwise stated.formulated the basis for reasonable surgical plan [4,5]. It
plays an important role in prognostic score for a variety of
tumors, such as Gleason score for prostate cancer [6],
Child-pugh classification for hepatocellular carcinoma [7],
SBR, WHO score for breast cancer [8], but the prognostic
effect of histopathology has never been reported in gastric
cancer. Moreover, there is not any effective way to identify
the prognosis of early gastric cancer.
The coexistence of different histological types of gas-
tric cancer determines the the complex characteristics of
clinical behavior and prognosis, the mixed histological
type accounted for over 25% of all gastric cancer [9,10].
Since major diagnostic principles are used, the highly
heterogeneous histological features of gastric cancer
were ignored, tumor biological behavior and prognostic
value of minor histological type were coved up [11]. We. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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histological classification of gastric cancer with a new
histological scoring method, which makes the histopatho-
logical variable to be an independent prognostic factor.
In this study, we attempted to evaluate the histological
characteristics and establish simple criteria using theFigure 1 Mixed histological type of gastric cancer in WHO classificatio
mucinous adenocarcinoma, final score: (1 + 3)/2 = 2, (B) medium differentia
final score: (2 + 3)/2 = 2.5 (C) high differentiated tubular adenocarcinoma m
final score: (1 + 3 + 4)/3 = 2.7, (D) high differentiated mixed with undifferenresults of histopathological tumor-related factors to
predict prognosis of patients with gastric carcinoma.Methods
All patients with gastric cancer who underwent surgery
at the Department of Surgical Oncology, First Hospital of
China Medical University, during January 1980 to December
2006 were entered into a prospectively maintained database.
Ethical approval for this research was obtained from the
Research Ethics Committee of China Medical University,
China. In total, 1077 patients underwent D2 lymphade-
nectomy and achieved radical (R0) resection for histologi-
cally proven gastric carcinoma. Follow-up was complete
for the entire study population to June 2005. Among
them, 24 died in the postoperative period and 43 were lost
to follow-up. Thus, 145 patients were excluded. Of the
remaining 932 patients, Median and mean follow-up
period were 31 and 54 months (range: 3–313 months),
respectively. Patients were treated exclusively by total
or subtotal gastrectomy with lymphadenectomy, according
to tumor location, adjuvant therapy or postoperative chemo-
therapy was not administered to any patient. Cancer-specific
survival was calculated from the date of primary surgical
resection to the date of gastric cancer associated death
or to the date of recorded cancer progression. Tumor
invasion (T), lymph node involvement (N) and TNM
stage were classified according to the 7th UICC/AJCC
(2012) staging systems.n. (A) high differentiated tubular adenocarcinoma mixed with
ted tubular adenocarcinoma mixed with mucinous adenocarcinoma,
ixed with signet ring cell carcinoma and mucinous adenocarcinoma,
tiated gastric cancer, final score: (1 + 5)/2 = 3.
Table 2 Univariate analysis of the prognostic factors for patients with gastric cancer in overall and early stage
Variables Overall Early stage
Cases n(%) 5-year OS(%) P value Cases n(%) 5-year OS(%) P value
Gender 932 0.311 90 82.2 0.07
Male 669 71.8 37.8 65 72.2 86.2
Female 263 28.2 43.1 25 27.8 72.0
Age(years) 0.062 0.32
≤65 533 57.2 34.3 66 73.3 83.3
>65 399 42.8 43.0 24 26.7 79.2
Size <0.001 0.714
≤4 cm 224 24.0 59.2 57 63.3 82.5
>4 cm 708 76.0 33.0 33 36.7 81.8
Location <0.001 0.149
Lower 672 72.1 42.1 75 83.3 85.3
Middle 99 10.6 37.6 9 10.0 66.7
Upper 115 12.3 36.5 6 6.7 66.7
Entire 46 4.9 25.4 0 0.0 0.0
Macroscopic Type <0.001
Early stage 90 10.7 81.0
Borrmann I 30 2.1 42.1
Borrmann II 145 15.6 40.7
Borrmann III 614 65.9 34.2
Borrmann IV 52 5.6 13.7
Lauren grade 0.003 0.218
Intestinal 455 48.8 50.4 38 42.2 86.5
Diffuse 477 51.2 37.1 52 57.8 73.1
Histologic type 0.334 0.263
Mixed-type 272 29.2 40.3 37 41.1 61.3
Well-differentiated 61 6.5 57.9 7 7.8 83.7
Medium-differentiated 112 12.0 43.7 8 8.9 53.9
Poorly-differentiated 365 39.2 37.5 34 37.8 40.2
Mucinous 58 6.2 38.6 1 1.1 100.0
Signet-ring cell 29 3.1 47.8 3 3.3 33.3
Undifferentiated 30 3.2 21.4 0 0.0 0.0
Squamous cell 5 0.5 25.0 0 0.0 0.0
Histologic type 2 0.504 0.958
Differentiated 380 40.8 37.6 59 65.6 83.1
Undifferentiated 552 59.2 40.5 31 34.4 80.6
Histologic type 3 0.032 0.016
Singal-type 684 73.3 39.3 56 62.2 89.1
Mixed-type 246 26.4 39.3 34 37.8 72.4
Histologic Grading <0.001 <0.001
1 63 6.8 82.5 30 30.0 93.3
2 352 37.7 62.0 45 50.0 88.6
3 399 42.8 26.2 17 18.9 78.6
4 118 12.6 6.8 1 1.1 0.0
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Table 2 Univariate analysis of the prognostic factors for patients with gastric cancer in overall and early stage
(Continued)
T Stage <0.001
T1 90 9.7 82.2
T2 185 19.8 50.8
T3 418 44.8 36.5
T4 239 25.6 19.0
N Stage <0.001 0.06
N0 288 30.9 63.8 65 72.2 86.2
N1 168 18.0 43.7 13 14.4 76.9
N2 189 20.3 34.0 10 11.1 70.0
N3 287 22.5 12.2 2 2.2 50.0
Lymphovascular invasion 0.032
Negative 208 22.3 40.7
Positive 724 77.7 22.6
Peritoneal metastasis 0.022
Absent 889 88.9 39.8
Present 43 11.1 19.5
Hepatic metastasis 0.014
Absent 878 90.3 38.7
Present 54 9.6 16.8
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According to highly heterogeneous histological features
and WHO classification of gastric cancer, we propose the
novel histological grading system. Aiming to develop and
validate the scoring system, the following statistical com-
puting methodologies were applied in the order indicated:
(1) According to the previous studies of histological
differentiation and malignant degree of gastric carcinoma,
non-mucinous adenocarcinoma (papillary adenocarcinoma
and high, medium and low differentiated tubular adeno-
carcinoma) were assigned as 1–3 points, respectively.
Mucinous adenocarcinoma was assigned as 3 points, signet
ring cell carcinoma was assigned as 4 points, undifferenti-
ated carcinoma was assigned as 4 points, a special type of
stomach cancer as 4 points (these score still needs further
refinement) (Table 1).
(2) The total score of gastric carcinoma was summed
by the original score of the primary histological type and
secondary type of gastric carcinoma. Then the total
score was divided by the number of histological types to
calculate the final score (The mean of the total score).
If it was composed of three or more histological type
of gastric tissues, The scores will aggregate all score of
histological type, then divideded by the number of
histological types to get the final score, as presented in
Figure 1. If the carcinoma was composed of a pure
histological type (All tumors were constituted by the
primary type), the score remains the final score.(3) Histological grading stage (H Stage) was divided
into four groups according to their scores, as follows:
H1 (≤2 points), H2 (2–3 points), H3 (3–4 points) and
H4 (4–5 points).
Statistical analysis
Each variable was used as an independent variable in a Cox
proportional hazards analysis run using the Kaplan-Meier
method. This was done to screen the variables for later
inclusion in a multivariable model. To be included in
the multivariable analysis, a variable had to be signifi-
cant at α of 0.1 for the Wald test. This was a test of the
null hypothesis that the coefficient for all levels of the
variable of interest was equal to zero.
All significant variables of the univariate analysis were
included in the first run of a multivariable Cox propor-
tionate hazard regression. In subsequent Cox regressions,
significantly different variables in their hazard ratios were
remained sequentially based on the z-statistic for the
individual levels of each categorical variable. To re-
main in the final model, a variable had to be significant
at α of 0.05 at all levels.
Results
As stated above, the study included 932 patients under-
going gastrectomy for gastric carcinoma from 1980 to
2005. All patients followed until death or for a max-
imum 313 months. The overall 5-year survival rate was
Table 3 Relationship between the prognostic factors and histological types for patients with gastric cancer
Variables Cases 932 Pure type 684 (73.61) Mixed type 246 (26.39) χ2 P value
Gender 0.532 0.466
Male 669 488 181
Female 263 198 65
Age(years) 0.039 0.843
≤65 533 391 142
>65 399 295 104
Size <0.001 0.983
≤4 cm 224 165 59
>4 cm 708 521 187
Location 0.081 0.96
Lower 672 495 178
Middle 99 103 38
Upper 115 88 30
Entire 46
Macroscopic Type 11.173 0.018
Early stage 90 66 34
Borrmann I 30 13 7
Borrmann II 145 119 26
Borrmann III 614 453 161
Borrmann IV 52 35 17
Lauren grade 0.189 0.003
Intestinal 455 368 128
Diffuse 477 318 118
T Stage 9.629 <0.001
T1 90 56 34
T2 185 140 45
T3 418 321 97
T4 239 169 70
N Stage 3.043 0.551
N0 288 213 75
N1 168 131 37
N2 189 135 54
N3 287 207 80
Lymphovascular invasion 8.794 0.038
Negative 208 378 121
Positive 724 300 124
Peritoneal metastasis 10.322 <0.001
Absent 889 672 215
Present 43 12 31
Hepatic metastasis 11.523 <0.001
Absent 878 667 209
Present 54 17 37
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Figure 2 The 5-year survival rates of gastric cancer patients with mixed form were lower than those with pure form, especially for
early stage. (A) Survival rates of all gastric cancer patients with mixed form were 48.2% and single form were 53.3%, P = 0.305. (B) Survival
rates of early gastric cancer patients with mixed form were 83.5% and single form were 95.8%, P < 0.01. (C) Survival rates of early gastric cancer
patients with mixed form were 40.8% and single form were 50.0%, P = 0.037.
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applied in this series. The frequencies of patient charac-
teristics and epidemiological results are summarized in
Table 2.
Difference of survival reflected by tumor-related fac-
tors such as tumor size, tumor depth, lymph node me-
tastasis was shown in Table 3. Compared to the pure
histological type, mixed histological type gastric cancer
was significant associated with tumor size, lymph node
metastasis and depth of invasion (all P < 0.05). All the
gastric cancer patients were stratified by advanced and
early stage. The 5-year survival rates of advanced and early
gastric cancer patients with mixed form were 40.8% and
83.5% respectively, which were lower than those with pure
form (50.0% and 95.8%, P < 0.01) ( Figure 2).
Patients stratified by Histological grading of 214
(55.9%), 182 (28.4%), 492 (15.7%) and 44 (28.4%) defined
Histological stage I, II, III and IV, respectively. Statisticallysignificant difference with stratification of early and ad-
vanced stage could be observed between patients with the
histological grading score, respectively. Mixed histological
type gastric cancer had worse prognosis in early and
advanced stage (Table 2). No significant difference was
observed regarding gender and age of the patients. Signifi-
cant correlation was observed between H grading scores
and all of the tumor-related factors (Table 4).
The T, N, and TNM stage are the best classification
system to classify overall survival of patients with gastric
carcinoma, however, there is no effective methodology
to evaluate the prognosis of early stage. The 5-year sur-
vival rates of gastric cancer patients stratified by histo-
logical grading showed there is no superiority compared
to T stage and N stage, but the 5-year survival rates of pa-
tients with early stage stratified by histological grading
was much better than N stage in predicting the prognosis
of the early stages, P < 0.01. Significant difference could be
Table 4 Comparison of relationship between Histological grading and prognositic factors
Histological grading P
Variables H1 (≤2) H2 (2–3) H3 (3–4) H4 (4–5)
Size <0.001
≤4 cm 61 39 117 7
>4 cm 153 143 375 37
Location
Lower 150 130 358 35
Middle 34 25 76 6
Upper 30 27 58 3
Entire
Macroscopic Type <0.001
Early stage 31 18 49 2
Borrmann I 10 2 7 1
Borrmann II 43 33 63 6
Borrmann III 127 123 334 30
Borrmann IV 3 6 38 5
Lauren grade <0.001
Intestinal 169 127 194 6
Diffuse 45 55 298 38
Histologic type <0.001
Differentiated 164 141 72 3
Un-differentiated 50 41 420 41
Depth of tumor <0.001
T1 30 17 42 1
T2 46 36 95 8
T3 92 89 223 14
T4 46 40 132 21
Node metastasis <0.001
N0 87 55 137 9
N1 42 37 83 6
N2 44 40 96 9
N3 41 50 176 20
Lymphovascular invasion <0.001
Negative 145 104 240 10







Zhu et al. BMC Cancer 2014, 14:663 Page 7 of 10
http://www.biomedcentral.com/1471-2407/14/663observed in survival curves between the early and ad-
vanced stage for the same patients, respectively (Figure 3).
The multivariate Cox stepwise proportional hazard
model identified Macroscopic type (HR, 1.226, P <0.001),Histological grading (HR, 1.316, P <0.001), T stage (HR,
1.340, P <0.001), N stage (HR, 1.425, P <0.001) as inde-
pendent predictors of prognosis. In the early gastric can-
cer, Histological grading (HR, 1.533, P <0.001), Tumor size
Figure 3 The 5-year survival rates of gastric cancer patients stratified by histological grading. (A) showed there is no superiority compared
to N stage (B) and T stage (C), but the 5-year survival rates of patients with early stage stratified by histological grading (D) was much better
than N stage (E) in predicting the prognosis of the early stages, P < 0.01. Significant difference could be observed in survival curves between
the early and advanced stage for the same patients, respectively.
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independent predictors of prognosis, histological grading
were proved to be the highest HR (Table 5).
Discussion
Generally, tumor stage composed of depth of tumor,
lymph node metastasis, and distant metastasis, might ac-
count for the most powerful indicator for the prognosis in
the majority of malignant tumors [12-15]. Conventional
histopathological variables that have been correlated with
prognosis of many malignant neoplasms plays an import-
ant role in prognostic score, such as Gleason score ofTable 5 Mutivariate analysis of the prognostic factors for pat
Variables Overall
HR 95% CI P
Size 1.220 0.958-1.554
Macroscopic type 1.226 1.086-1.385
Lauren grade 1.181 0.894-1.076
Histologic type 1.136 0.764-1.352
Histologic grading 1.316 1.182-1.465
N Stage 1.425 1.328-1.529
T Stage 1.340 1.181-1.522
Distant metastasis 1.215 0.935-1.650prostate cancer, Child-pugh classification of hepatocellular
carcinoma, SBR, WHO score of breast cancer [8,16,17].
Nevertheless, for gastric cancer, separated from other
cancers, the prognostic value of these factors has not
been consistently recognized. It has been reported that
there is no relationship between gastric histological type
and prognosis, there is no comprehensive pathological
conditions or anything about gastric histopathological
differentiation in the reflection of gastric cancer staging
and prognosis [18].
However, the practical value of some of histopatho-
logical variables is limited due to complexity of gastricients with gastric cancer in overall and early stage
Early stage
value HR 95% CI P value
0.107 1.412 1.026-1.545 <0.001
<0.001 1.365 0.922-1.463 0.103
0.684 1.133 0.754-1.042 0.725
0.722 1.136 0.764-1.352 0.722
<0.001 1.533 0.838-1.734 <0.001
<0.001 1.213 1.096-1.416 0.036
<0.001
0.116
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nancy subtypes and ambiguity of tumor biological be-
haviors [19]. Despite their histological variability, usually
one of four patterns predominates. The diagnosis is based
on the predominant histological pattern [20]. Histologi-
cally, most subtypes of carcinoma occur in early gastric
cancer in either pure or mixed forms. We performed this
study to compare pure or mixed gastric cancer forms of
prognosis, The 5-year survival rates of advanced and early
gastric cancer patients with mixed form were 40.8% and
83.5% respectively, which were lower than those with pure
form (50.0% and 95.8%, P < 0.01).
Proportion of mixed forms gastric cancer patients with
N0 stage were significantly lower than with a pure type,
patients of mixed type are more likely to lymph node
metastasis. Mixed forms were significantly correlated with
T stage, so patients were stratified into early and advanced
stage, univariate analysis and survival curve showed 5 -year
survival of mixed type of early gastric cancer was signifi-
cantly lower than that that of a pure type, and there was lit-
tle difference in the advanced stage.
With the histological grading score, there is signifi-
cantly different between the 5-year survival curves of H
Stage, prognosis of early gastric cancer could be identified
obviously, which is not reflected in any other current clas-
sification. Indeed, statistically significant difference with so
strict stratification was observed between patients with H
Stage 1–4.
The T, N, or TNM classification system could exert an
excellent ability to classify overall survival of patients
with gastric carcinoma also in the current study. How-
ever, in early gastric cancers, only small mucosal (<4 cm),
superficial (>4 cm) and PenA, PenB may have a low inci-
dence of lymph node metastasis with good prognosis after
surgery [21]. There is no effective methodology to evaluate
the prognosis of early gastric cancer. Our new histological
grading provides a new tragedy to identify the prognosis
of early gastric cancer.
Of course, TNM classification system could exert an
excellent ability to classify survival of patients with gastric
carcinoma also in the current study. Therefore, H grading
system newly devised as well as TNM classification system
could classify the prognosis of patients with gastric carcin-
oma with a strict stratification. This score system would
provide objective information regarding the outcome of pa-
tients treated with curative resection for gastric carcinoma.
In conclusion, H Stage that can be utilized in the ma-
jority of the institutes would be quite simple criteria to
predict prognosis of gastric carcinoma with a strict
stratification.
Conclusions
The histological score that we developed in the research
exert an excellent ability to classify survival of patientswith gastric carcinoma, it could classify the prognosis of
patients with gastric carcinoma with a strict stratifica-
tion. The histological score is an independent factor of
gastric cancer. It also provides a new strategy and par-
ameter for evaluating the biological behavior and prog-
nosis of gastric cancer.
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